Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Vanner

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Alimentary Pharmacology & Therapeutics|February 2, 2019
Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkersAmmar Hassanzadeh Keshteli, Karen L Madsen, Rupasri Mandal, et al.
Alimentary Pharmacology & Therapeutics|March 29, 2019
Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' replyAmmar Hassanzadeh Keshteli, Karen L Madsen, Rupasri Mandal, et al.
The Journal of Physiology|June 24, 2006
Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and miceSilvia Amadesi, Graeme S Cottrell, Lorna Divino, et al.
Gastroenterology|August 23, 2011
Brain-gut interactions increase peripheral nociceptive signaling in mice with postinfectious irritable bowel syndromeCharles Ibeakanma, Fernando Ochoa-Cortes, Marcela Miranda-Morales, et al.
Scientific Reports|June 15, 2022
Small-molecule metabolome identifies potential therapeutic targets against COVID-19Sean Bennet, Martin Kaufmann, Kaede Takami, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2013
LC-MS/MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolitesPauline Le Faouder, Vincent Baillif, Ian Spreadbury, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 8, 2008
Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesiaWalter E B Sipe, Stuart M Brierley, Christopher M Martin, et al.
British Journal of Pharmacology|March 27, 2018
Co-expression of μ and δ opioid receptors by mouse colonic nociceptorsRaquel Guerrero-Alba, Eduardo Emmanuel Valdez-Morales, Nestor Nivardo Jiménez-Vargas, et al.
Inflammatory Bowel Diseases|March 27, 2024
Crohn's Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE StudyCharles N Bernstein, Remo Panaccione, Zoann Nugent, et al.
BMJ Open|October 22, 2020
IMAGINE Network's <u>M</u>ind <u>A</u>nd <u>G</u>ut <u>I</u>nteractions <u>C</u>ohort (MAGIC) Study: a protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndromePaul Moayyedi, Glenda MacQueen, Charles N Bernstein, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Alimentary Pharmacology & Therapeutics|February 2, 2019
Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkersAmmar Hassanzadeh Keshteli, Karen L Madsen, Rupasri Mandal, et al.
Alimentary Pharmacology & Therapeutics|March 29, 2019
Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' replyAmmar Hassanzadeh Keshteli, Karen L Madsen, Rupasri Mandal, et al.
The Journal of Physiology|June 24, 2006
Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and miceSilvia Amadesi, Graeme S Cottrell, Lorna Divino, et al.
Gastroenterology|August 23, 2011
Brain-gut interactions increase peripheral nociceptive signaling in mice with postinfectious irritable bowel syndromeCharles Ibeakanma, Fernando Ochoa-Cortes, Marcela Miranda-Morales, et al.
Scientific Reports|June 15, 2022
Small-molecule metabolome identifies potential therapeutic targets against COVID-19Sean Bennet, Martin Kaufmann, Kaede Takami, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 9, 2013
LC-MS/MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolitesPauline Le Faouder, Vincent Baillif, Ian Spreadbury, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 8, 2008
Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesiaWalter E B Sipe, Stuart M Brierley, Christopher M Martin, et al.
British Journal of Pharmacology|March 27, 2018
Co-expression of μ and δ opioid receptors by mouse colonic nociceptorsRaquel Guerrero-Alba, Eduardo Emmanuel Valdez-Morales, Nestor Nivardo Jiménez-Vargas, et al.
Inflammatory Bowel Diseases|March 27, 2024
Crohn's Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE StudyCharles N Bernstein, Remo Panaccione, Zoann Nugent, et al.
BMJ Open|October 22, 2020
IMAGINE Network's <u>M</u>ind <u>A</u>nd <u>G</u>ut <u>I</u>nteractions <u>C</u>ohort (MAGIC) Study: a protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndromePaul Moayyedi, Glenda MacQueen, Charles N Bernstein, et al.
Pageof 7